Back to company

Target Biotech ApS: Financial statements 2023

CVR: 39676478

Target Biotech ApS (CVR 39676478) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 63,828 and a net result of DKK 3,926 compared with DKK 56,725 the year before. That is a decrease of 84.2% compared with the year before. Equity amounted to DKK 332,792. The solvency ratio was 68.6%. The company had 1 employee in the financial year.

Gross Profit
63,828 kr.
Profit/Loss
3,926 kr.
Equity
332,792 kr.
Total Assets
484,952 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-64 t.4 t.333 t.1
2022-403 t.57 t.329 t.1
2021-487 t.88 t.272 t.1
2020-365 t.24 t.184 t.1
2019-221 t.57 t.160 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Target Biotech ApS: The 2022 annual report is outJun 27, 2023

Target Biotech ApS has published its annual report for 2022. Gross profit came to DKK 402,821, and the net result was DKK 56,725.

About Target Biotech ApS

Target Biotech ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2018. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Peter Horn Møller. The company is owned by Peter Horn Møller. The company has 0 employees. In 2025, the company reported a gross profit of DKK -19,344 and a net result of DKK -7,028,421 compared with DKK 23,952,623 the year before. Equity amounted to DKK 10,735,912.

Other financial years